The signal is clear:
Europe wants AI-driven innovation in healthcare — but not at the expense of data protection.
What Matters
• Support for scale: Regulators back efforts to streamline clinical trials and enable cross-border data use
• No compromise on fundamentals: General Data Protection Regulation safeguards remain non-negotiable
• Stricter rules on sensitive data: Clear accountability between controllers, tight limits on data retention, and strict conditions for reusing clinical data (especially for AI training)
The underlying shift is structural:
• There is no longer any tolerance for “implied” legal bases in AI pipelines
• Secondary use of data is now a regulatory hotspot
• Ambiguity = risk
For health tech, pharma, and AI leaders, this changes the game:
If your models rely on patient or genetic data, you need:
• Explicit legal grounds
• Clearly defined purposes
• Verifiable safeguards
No shortcuts. No gray areas.
Bottom line:
Europe is not slowing AI in healthcare — it’s forcing it to mature within strict, rights-centric boundaries.
And that’s where many organizations will struggle.
How S8fe.ai Supports
S8fe.ai helps organizations operationalize GDPR requirements across AI and healthcare use cases. We enable automated DPIAs, consent governance, and data lifecycle management, reducing regulatory risk while accelerating innovation.
Source: https://www.edpb.europa.eu/our-work-tools/our-documents/edpbedps-joint-opinion/edpb-edps-joint-opinion-32026-proposal-european_en